Although there is no cure for Von Hippel-Lindau (VHL) disease, the symptoms it causes can be treated. Often, the most common ...

Von Hippel-Lindau syndrome is a genetic disorder where tumors can grow in multiple organs throughout the body, according to the National Cancer Institute. Zamora faces one count of injury to a ...

Belzutifan is indicated as monotherapy to treat adult patients with von Hippel-Lindau disease who require therapy for associated localized renal cell carcinoma, central nervous system ...

John Hepworth is one of about 800 people in England who lives with Von-Hippel Lindau disease A man has been given new hope against an inherited disease that is thought to have affected at least ...

Welireg (belzutifan), an oral HIF-2 alpha inhibitor, has been approved by the FDA for adults with von Hippel-Lindau (VHL) disease, an inherited condition caused by a mutation in the VHL gene that ...

Merck, known as MSD outside of the United States and Canada, announced that the National Medical Products Administration (NMPA) in China has approved Welireg (belzutifan), for the treatment of adult ...

The Dere lab specializes in kidney cancer and VHL (von Hippel Lindau) disease focused on understand fundamental aspects of how non-chromatin functions of chromatin modifiers contribute to oncogenesis.

Merck (NYSE:MRK) has received a positive recommendation from EU regulators for its drug Welireg as a treatment for certain patients with von Hippel-Lindau disease, or VHL, and advanced kidney cancer.